A. Peter Thompson

Affiliations

  • at Edgewise Therapeutics Inc. (EWTX), 2025-06-18
  • Director at Sionna Therapeutics Inc. (SION), 2025-06-16
  • at Corvus Pharmaceuticals Inc. (CRVS), 2025-06-16
  • Director at Ars Pharmaceuticals Inc. (SPRY), 2024-08-28
  • Director at Alpine Immune Sciences Inc. (ALPN), 2024-05-21
  • Large Shareholder, Director at Decibel Therapeutics Inc. (DBTX), 2022-06-21
  • Director at Janux Therapeutics Inc. (JANX), 2022-06-16
  • Large Shareholder, Director at Pmv Pharmaceuticals Inc. (PMVP), 2021-06-09
  • Large Shareholder, Director at Prevail Therapeutics Inc. (PRVL), 2021-01-26
  • Large Shareholder, Director at Synthorx Inc. (THOR), 2020-01-24
  • Director at Principia Biopharma Inc. (PRNB), 2018-09-13
  • Director at Adaptimmune Therapeutics Plc (ADAP), 2018-06-06
  • Large Shareholder, Director at Response Biomedical Corp (RBM), 2016-12-02
  • Director at Pronai Therapeutics Inc (DNAI), 2015-07-21
  • Director at Mirati Therapeutics Inc. (MRTX), 2013-07-12
  • Director at Anthera Pharmaceuticals Inc (ANTH), 2012-05-11
  • Officer, Director at Trubion Pharmaceuticals Inc (TRBN), 2009-05-26
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
EWTX $20.13 124,193 $2,500,005.09 443,792 2025-04-03 Filing
EWTX $20.13 372,578 $7,499,995.14 14,809,075 2025-04-03 Filing
SION $18.00 550,000 $9,900,000.00 3,704,959 2025-02-10 Filing
EWTX $11.00 454,545 $4,999,995.00 14,436,497 2024-01-23 Filing
SPRY $6.20 500,000 $3,100,000.00 8,019,187 2023-08-29 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
SPRY $13.00 83,695 $1,088,035.00 0 2024-08-26 Filing
SPRY $13.03 69,500 $905,585.00 83,695 2024-08-23 Filing
SPRY $12.94 391,482 $5,065,777.08 153,195 2024-08-22 Filing
SPRY $14.61 13,300 $194,313.00 544,677 2024-08-21 Filing
SPRY $13.52 394,400 $5,332,288.00 557,977 2024-08-21 Filing